Efficacy of dual PI-3K and mTOR inhibitors in vitro and in vivo in acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of dual PI-3K and mTOR inhibitors in vitro and in vivo in acute lymphoblastic leukemia

Published:2014-07-25 Issue:21 Volume:5 Page:10460-10472
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wong Jacky¹,Welschinger Robert¹,Hewson John¹,Bradstock Kenneth F.²,Bendall Linda J.¹

Affiliation:

1. Centre for Cancer Research, Westmead Millennium Institute, University of Sydney, Westmead, Australia

2. Department of Haematology, Westmead Hospital, Westmead. NSW. Australia

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy and Apoptosis Cross-Talk in Response to Epigallocatechin Gallate in NALM-6 Cell Line;Jundishapur Journal of Natural Pharmaceutical Products;2023-11-10

2. In the Pipeline—Emerging Therapy for ALL;Pathogenesis and Treatment of Leukemia;2023

3. Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects;International Journal of Molecular Sciences;2022-03-30

4. Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects;Expert Review of Hematology;2021-11-02

5. Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol;Frontiers in Oncology;2021-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP